Cochlear | COH - Market Capitalization


Cochlear reported AUD9.01B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 4.84B 1.48B Aug/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Cochlear AUD 7.9B 9.15B Aug/2026
CSL USD 60.19B 4.3B Aug/2026
Fisher Paykel Healthcare NZD 21.96B 201.12M Jun/2026
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Mayne Pharma AUD 252.67M 153.55M Dec/2025
Mesoblast USD 2.69B 362.49M Aug/2026
Monash IVF AUD 266.9M 19.48M Aug/2026
Nanosonics AUD 963.21M 241.07M Aug/2026
Polynovo AUD 849.74M 24.18M Dec/2025
Ramsay Health Care AUD 10.02B 2.09B Aug/2026
Regis Healthcare AUD 1.83B 271.12M Aug/2026
ResMed USD 47.56B 4.96B Mar/2026
Sigma Healthcare AUD 2.9B 1.78B Jul/2026
Somnomed AUD 79.04M 27.72M Jun/2023
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Telix Pharmaceuticals AUD 5.63B 2.18B Aug/2026